Print

Kaken Pharmaceuticals Reveals Results From Early Phase II Clinical Trial On KCB-1D 
10/19/2005 5:11:54 PM

Kaken Pharmaceutical has announced that it has completed an early phase II clinical trial of KCB-1D, a drug candidate for the treatment of periodontitis, and detailed results were presented at the 47th Annual Meeting in Autumn of the Japanese Society of Periodontology (Sendai, October 5) by Osaka University Professor Shinya Murakami.
//-->